Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
21
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Troubadour is a London-based menswear brand specialising in designing minimalist bags & accessories by combining performance design with a clean & modern aesthetic feel. The company has delivered its products to 60+ wholesalers. It is backed by Pembroke VCT, a luxury-focused venture capital firm based in London. Troubadour is planning to work with non-traditional retailers including Ritz Carlton, Four Seasons, and Equinox. It has also collaborated with many world-renowned brands such as British tailors 'Thom Sweeney' and British essentials brand 'Sunspel' that is famous for clothing James Bond. The company has also been a case study for classes at the Harvard Business School. With the investment, the company will support sales growth to its customers and retail partners and also fund working capital requirements from its forecast growth plan.
days to go:
Expired
investment:
£621,240
London Examinations Board (LEB) connects learners to qualifications. LEB are predominantly a distance learning provider however they understand that distance learning isn't for everyone and have therefore approved select colleges to offer appropriate LEB courses. LEB only promotes superior internationally recognised courses.
days to go:
Expired
investment:
£141,465
Gunna Drinks is a company that manufactures and sells craft soft drinks, consisting of natural juices with less than 5% sugar and no artificial colours or flavours. They have outshone established competitors like Gingerella, Fentimans & FeverTree in taste tests, and its recipes draw inspiration from around the world. Gunna is stocked in major supermarkets and convenience stores across the UK such as Co-op, Sainsbury’s, Amazon, Ocado, and JD Wetherspoon. Gunna Drinks has experienced 85% revenue growth in 2019 and was overfunded by 78% in its last crowdfunding round. The company will utilise the investment to boost consumer marketing to drive rapid revenue growth and develop new products and flavours.
days to go:
Expired
investment:
£274,880
Hansine is a luxury resort wear brand designed with strong ethical values and produced in London to the booming global market sector. The product's initial launch has proved its global demand with retailers like Liberty and Neiman Marcus. Hansine aims at becoming a definitive luxury destination wear brand. This brand has been worn by the topmost global influencers, and it has been featured by high-profile media platforms such as FT, Elle, Grazia, and The Telegraph. With the proceeds, the company will invest in production, facilitate the third phase of the business plan, staffing and marketing.
days to go:
Expired
investment:
£56,820
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go:
Expired
investment:
£2,160,000
